BPC-157 is a therapeutic peptide, not a controlled substance or narcotic, and it does not metabolize into anything these tests are designed to detect
These include a high affinity for the benzazepine ligands SCH 23390, SCH 39166, and SKF 83566, all selective antagonists for these subtypes
The leading cause of denial is missing or incomplete drug documentation
Certificates of Analysis BPC-157 From $95.99 $32.99 Premium BPC-157 Available in Canada Strictly for Research Purposes BPC-157 is one of the most widely recognized and extensively discussed peptides in modern peptide research
Opportunistic infections, including fungal and mycobacterial infections, have been seen with all TNF inhibitors and all agents carry a black box warning on their labeling about these infections
Is the BPC-157 peptide prohibited under WADA for athletes